MONDELLO, Stefania
 Distribuzione geografica
Continente #
EU - Europa 5.964
NA - Nord America 4.077
AS - Asia 1.405
SA - Sud America 25
AF - Africa 7
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.489
Nazione #
US - Stati Uniti d'America 4.056
RU - Federazione Russa 2.985
IE - Irlanda 1.159
CN - Cina 741
SE - Svezia 688
SG - Singapore 529
IT - Italia 364
FI - Finlandia 201
DE - Germania 129
PL - Polonia 126
GB - Regno Unito 118
UA - Ucraina 84
IN - India 44
VN - Vietnam 30
BE - Belgio 24
FR - Francia 23
BR - Brasile 21
CA - Canada 17
NL - Olanda 17
ID - Indonesia 13
AT - Austria 12
IR - Iran 12
CZ - Repubblica Ceca 11
KR - Corea 8
JP - Giappone 7
AU - Australia 6
EG - Egitto 5
IQ - Iraq 5
DK - Danimarca 4
RO - Romania 4
CH - Svizzera 3
EU - Europa 3
HU - Ungheria 3
SK - Slovacchia (Repubblica Slovacca) 3
ES - Italia 2
HK - Hong Kong 2
LK - Sri Lanka 2
LT - Lituania 2
MX - Messico 2
PK - Pakistan 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 11.489
Città #
Moscow 2.971
Dublin 1.157
Chandler 780
Singapore 416
Nyköping 379
Jacksonville 324
Beijing 253
Princeton 241
Medford 218
Dearborn 184
Des Moines 182
Cambridge 175
Ashburn 173
Messina 154
Warsaw 126
Boardman 93
Ann Arbor 89
Wilmington 88
New York 86
Houston 62
Lancaster 57
San Mateo 55
Shenyang 55
Munich 53
Jinan 51
Nanjing 36
Woodbridge 36
Seattle 35
Helsinki 30
Tianjin 30
Dong Ket 28
Haikou 28
Zhengzhou 26
Taizhou 24
Brussels 22
Hebei 22
Pune 22
Los Angeles 21
Rome 20
Ningbo 17
Hangzhou 16
Nanchang 15
Catania 14
Falls Church 14
Hyderabad 14
Norwalk 14
Jiaxing 13
Vienna 12
Brno 11
Jakarta 11
Fuzhou 10
Lappeenranta 10
Washington 10
Changsha 9
Lanzhou 9
Milan 9
Hefei 8
Bremen 7
London 7
Ottawa 7
Tappahannock 7
Paris 6
São Paulo 6
Taiyuan 6
Miami 5
Redwood City 5
San Francisco 5
Tokyo 5
Wuhan 5
Arlington 4
Auburn Hills 4
Gainesville 4
Guangzhou 4
New Delhi 4
Nuremberg 4
Phoenix 4
The Dalles 4
Cairo 3
Kunming 3
Naples 3
Piazza Armerina 3
Riva 3
Santa Clara 3
Seoul 3
Shanghai 3
Allschwil 2
Ampara 2
Ardabil 2
Augusta 2
Baghdad 2
Belo Horizonte 2
Budapest 2
Canberra 2
Castlebar 2
Castrolibero 2
Catanzaro 2
Chicago 2
Chongqing 2
Columbia 2
Council Bluffs 2
Totale 9.175
Nome #
Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury 2.994
Autoantibodies in traumatic brain injury and central nervous system trauma. 115
Accuracy of Cystosonography without Voiding Phase in the Diagnosis of Vesicoureteral Reflux in Children: A Variant of the Original Technique 100
Emerging markers of cachexia predict survival in cancer patients. 94
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 94
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 89
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 87
Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients 84
Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions. 83
Perceived Stress in a Gender Perspective: A Survey in a Population of Unemployed Subjects of Southern Italy 82
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 80
Data comparison between pharmacological induction of labour and spontaneous delivery. A single centre experience 80
Nodal Ratio as a Prognostic Factor in Patients with Four or More Positive Axillary Nodes Treated with Breast-conserving Therapy and Regional Nodal Irradiation 79
A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans 78
Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury 76
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 72
EFFETTI DEL LAVORO A TURNI E NOTTURNO SU LIVELLI COGNITIVI E STATI DELL’UMORE NEI MEDICI IN FORMAZIONE SPECIALISTICA: DATI PRELIMINARI 70
Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients 67
Ubiquitin C-Terminal Hydrolase (UCH-L1): Correlations Exist Between Biofluid Kinetics and Clinical Outcome In Severe Traumatic Brain Injury Patients 66
p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma. 66
Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options 66
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 65
Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study 65
Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut. 64
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 63
alphaII-Spectrin Breakdown Products (SBDPs): Diagnosis and Outcome in Severe Traumatic Brain Injury Patients 63
Bioinformatics approach to understanding interacting pathways in neuropsychiatric disorders. 62
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 61
Renal complications in oncohematologic patients. 61
Complications of trauma patients admitted to the ICU in level i academic trauma centers in the United States 60
Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial 59
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 58
Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice 57
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 57
Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report 56
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model 56
Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment 56
Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 56
Anesthetic techniques and cancer recurrence after surgery. 56
Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 55
Ubiquitin Carboxy-Terminal Hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure 55
High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients 55
Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report 54
Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats 54
Psoriasis and cardiovascular risk: correlation between psoriasis and cardiovascular functional indices 54
Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2 54
Fast Magnetic Resonance Enterography Protocol for the Evaluation of Patients with Crohn's Disease: A Pilot Study 54
Night shift work in resident physicians: does it affect mood states and cognitive levels? 54
Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy 54
Lymphocytic vasculitis associated with icodextrin. 53
Elevated Levels of Serum Glial Fibrillary Acidic Protein Breakdown Products in Mild and Moderate Traumatic Brain Injury Are Associated With Intracranial Lesions and Neurosurgical Intervention. 53
Method to Detect, Monitor and Promote Neural Regeneration and Improvement of Cognitive Function in a Subject Suffering from Neural Injury 53
Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. 53
Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices 52
Biokinetic Analysis of Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Severe Traumatic Brain Injury Patient Biofluids 52
Angiotensin receptor antagonists: a potential neuroprotective strategy after brain trauma*. 51
Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients 51
Quantitative cerebrospinal fluid biokinetic parameters of alpha II-spectrin breakdown products in severe traumatic brain injury patients 50
Preoperative-Induced Mild Hypothermia Attenuates Neuronal Damage in a Rat Subdural Hematoma Model 50
Assessing Neuro-Systemic & Behavioral Components in the Pathophysiology of Blast-Related Brain Injury. 50
Biomarkers 50
Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats 49
Blood-based Diagnostics of Traumatic Brain Injury 49
CSF and Plasma Amyloid-b Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury: Results of a Pilot Study 49
Genotoxic effects of anesthetic agents: an update. 48
UCH-L1 levels in CSF and Serum: Diagnosis and Outcome in Severe Traumatic Brain Injury Patients 47
A simulated fast magnetic resonance enterography protocol in patients with Crohn's disease: a retrospective, randomized, double-blind study. 47
Changes in Brain Biomarkers and Brain Tissue Oxygenation Following Severe Head Injury: A Case Series 46
The hypothalamic-neurohypophyseal system: current and future treatment of vasopressin and oxytocyn related disorders. 46
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research 46
New astroglial injury-defined biomarkers for neurotrauma assessment 46
Translating biomarkers research to clinical care: applications and issues for rehabilomics. 45
The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage. 45
CSF protein biomarker panel for assessment of neurotoxicity. 45
ECR 2018 - BOOK OF ABSTRACTS 45
Development of A TBI Diagnostic Assay System For Multiple Levels Of Care 44
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. 43
ASSESSING A NECROSIS AND APOPTOSIS INDEX USING CSF alpha II-SPECTRIN BREAKDOWN PRODUCT LEVELS IN SEVERE TBI 43
null 43
Imaging as a biomarker in drug discovery for Alzheimer's disease: Is MRI a suitable technology? 43
Systems Biology, Bioinformatics, and Biomarkers in Neuropsychiatry 43
Alpha-synuclein Levels in the Cerebrospinal Fluid of Patients with Parkinson’s Disease and Atypical Parkinsonian Disorders 42
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 42
Brain Biomarkers and Brain Tissue Oxygenation: Changes and Correlations Following Severe Head Injury 42
Microvascular imaging ultrasound (MicroV) and power Doppler vascularization analysis in a pediatric population with early scrotal pain onset 42
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine. 41
Toward Improved Prediction of Outcome In Traumatic Brain Injury: Comparison Between Computed Tomographic Classifications And The Serum Biomarker UCH-L1 40
Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI 40
Family, lifestyles and new and old type of smoking in young adults: insights from an italian multiple-center study 40
Biofluid proteomics and biomarkers in traumatic brain injury 40
Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk 39
CLINICAL UTILITY OF SERUM LEVELS OF UBIQUITIN C-TERMINAL HYDROLASE AS A BIOMARKER FOR SEVERE TRAUMATIC BRAIN INJURY. 38
Biokinetic Analysis of Ubiquitin C-terminal Hydrolase (uch-l1) In Severe Traumatic Brain Injury Patient Biofluids 38
Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury 38
Mesenchymal stem cells in the treatment of traumatic brain injury 38
Epidemiology and clinical characteristics of traumatic brain injury in Lebanon A systematic review 38
Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity 37
Novel biomarker signatures for idiopathic REM sleep behavior disorder: A proteomic and system biology approach 37
Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma 37
Preterm birth: incidence, risk factors and second trimester cervical length in a single center population. A two-year retrospective study 37
Totale 8.516
Categoria #
all - tutte 52.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020521 0 0 0 0 0 0 107 82 25 133 156 18
2020/20211.210 60 18 274 45 184 51 18 162 103 172 59 64
2021/20221.216 7 90 18 60 42 15 64 61 18 119 181 541
2022/20233.077 290 191 131 234 207 295 16 162 1.416 21 81 33
2023/20241.713 64 182 55 68 84 187 15 42 7 142 486 381
2024/20253.005 797 786 340 612 254 189 27 0 0 0 0 0
Totale 12.069